ENTERA BIO LTD's ticker is ENTX and the CUSIP is M40527109.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $17 | +21.4% | 23,400 | +45.3% | 0.00% | – |
Q2 2023 | $14 | +16.7% | 16,100 | +54.8% | 0.00% | – |
Q1 2023 | $12 | -88.2% | 10,400 | -92.6% | 0.00% | – |
Q4 2022 | $102 | -99.5% | 139,600 | +555.4% | 0.00% | – |
Q3 2022 | $22,000 | -80.5% | 21,300 | -46.9% | 0.00% | – |
Q4 2021 | $113,000 | -75.4% | 40,100 | -66.7% | 0.00% | -100.0% |
Q1 2021 | $459,000 | +488.5% | 120,407 | +66.8% | 0.00% | – |
Q4 2020 | $78,000 | – | 72,186 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 1,791,363 | $6,825,000 | 4.45% |
XTX Topco Ltd | 11,559 | $44,000 | 0.02% |
Renaissance Technologies | 120,407 | $459,000 | 0.00% |
Tower Research Capital LLC (TRC) | 21,999 | $84,000 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 38,611 | $147,000 | 0.00% |
Clearstead Advisors, LLC | 500 | $2,000 | 0.00% |
Allworth Financial LP | 100 | $0 | 0.00% |
UBS Group AG | 1,614 | $6,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |